483
Balamurali K. Ambati , M.D., Ph.D.Balamurali K. Ambati , M.D., Ph.D. – FDA 483, Apr 4, 2019
Record Details
An FDA inspection of Balamurali K. Ambati, M.D., Ph.D, MBA, Clinical Investigator in Eugene, OR, revealed a critical failure to submit an Investigational New Drug (IND) application. This omission occurred prior to conducting a clinical investigation involving an unapproved combination product. The study, which began in April 2017 and is ongoing, proceeded without the required FDA authorization, posing a significant regulatory non-compliance issue.
View Company Profile
ID · 5e6088ad-c61f-4254-805a-3c4412368071
Other documents for Balamurali K. Ambati , M.D., Ph.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.